MGNX – macrogenics, inc. (US:NASDAQ)

News

MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
MacroGenics (MGNX) had its price target raised by Barclays PLC from $3.00 to $4.00. They now have an "overweight" rating on the stock.
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures [Yahoo! Finance]
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com